Global Alignment, Coordination and Collaboration in Perinatal Research: The Global Obstetrics Network (GONet) Initiative

Abstract

Large clinical studies provide information and insight that are used to develop clinical guidelines. In view of the large sample sizes needed, many researchers have initiated multicenter studies. In some situations, the activities of these groups have led to networks, through which multiple trials have been executed over a longer period of time. The Global Obstetrics Network (GONet) was formed to link the different types of networks. The GONet mission is “to provide a forum for international interaction and collaboration among groups that perform clinical trials and observational studies in maternal fetal medicine and obstetrics.” The purpose is to foster communication between groups to improve ongoing and future trials. This will open new avenues for cooperation in the design and conduct of large international trials, in seeking funding, and in highlighting evidence. The expectation is that this will lead to better studies and more efficient use of resources and minimize duplication. Furthermore, the group will provide insight and camaraderie, cooperate on data elements to allow future collaborations, and identify and highlight the pressing issues in maternal–fetal medicine. Here we describe the GONet mission, its objectives, structure and function, current collaborators, and plans for the future.

Keywords

Global Obstetrics Network - multicenter studies - trial collaboration - maternal–fetal medicine and obstetrics

• References

• 1 Altman DG. Better reporting of randomised controlled trials: the CONSORT statement. BMJ 1996; 313: 570-571
• 2 Pocock SJ. Clinical Trials: A Practical Approach. 1st ed. Chichester, UK: John Wiley & Sons; 1983
• 3 Senn S. Statistical Issues in Drug Development. 1st ed. Chichester, UK: Wiley; 1997
• 4 Kenyon SL, Taylor DJ, Tarnow-Mordi W. ORACLE Collaborative Group. Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. Lancet 2001; 357: 989-994
• 5 Kenyon SL, Taylor DJ, Tarnow-Mordi W. ORACLE Collaborative Group. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. Lancet 2001; 357: 979-988
• 6 Kenyon SL, Pike K, Jones DR , et al. Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial. Lancet 2008; 372: 1319-1327
• 7 Hills RK, Daniels J. Assessing new interventions in women's health. Best Pract Res Clin Obstet Gynaecol 2006; 20: 713-728
• 8 Lasagna L. Problems in publication of clinical trial methodology. Clin Pharmacol Ther 1979; 25 (5 Pt 2) 751-753
• 9 Raza A, Chien PF, Khan KS. Multicentre randomised controlled trials in obstetrics and gynaecology: an analysis of trends over three decades. BJOG 2009; 116: 1130-1134
• 10 Thom EA, Rouse DJ. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. What we have learned about conducting randomized controlled trials in the NICHD MFMU network. Semin Perinatol 2003; 27: 253-260
• 11 Hannah ME, Hannah WJ, Hewson SA, Hodnett ED, Saigal S, Willan AR. Term Breech Trial Collaborative Group. Planned caesarean section versus planned vaginal birth for breech presentation at term: a randomised multicentre trial. Lancet 2000; 356: 1375-1383
• 12 Poston L, Briley AL, Seed PT, Kelly FJ, Shennan AH. Vitamins in Pre-eclampsia (VIP) Trial Consortium. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet 2006; 367: 1145-1154
• 13 Norman JE, Mackenzie F, Owen P , et al. Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis. Lancet 2009; 373: 2034-2040
• 14 Shennan AH, Crawshaw S, Briley A , et al. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study. BJOG 2006; 113: 65-74
• 15 Groom KM, Shennan AH, Jones BA, Seed P, Bennett PR. TOCOX—a randomised, double-blind, placebo-controlled trial of rofecoxib (a COX-2-specific prostaglandin inhibitor) for the prevention of preterm delivery in women at high risk. BJOG 2005; 112: 725-730
• 16 Comparative Obstetric Mobile Epidural Trial (COMET) Study Group UK. Effect of low-dose mobile versus traditional epidural techniques on mode of delivery: a randomised controlled trial. Lancet 2001; 358: 19-23
• 17 Schuit E, Stock S, Groenwold RH , et al. Progestogens to prevent preterm birth in twin pregnancies: an individual participant data meta-analysis of randomized trials. BMC Pregnancy Childbirth 2012; 12: 13